直觉外科

Intuitive Surgical EVP Curet Buys, Sells Shares Amidst Market Volatility.

Bollinger Bands Narrowing, KDJ Death Cross on Intuitive Surgical's 15min Chart

Intuitive Surgical

Intuitive Surgical's da Vinci 5 System Gains FDA Approval for Cardiac Procedures

Intuitive Surgical: Q4 2025 Earnings Beat, 2026 and 2027 Earnings Growth Expected

Lam Research

United Rentals

Danaher

Linde

Fiserv

The Progressive

NZS Capital Q4 2025 Shareholder Letter: Portfolio Returns and Performance Overview

Catalyst<ul> <li>Most analysts rate ISRG Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state and we need to pay attention to the risk of decline.</li> <li>Bearish signals are obviously dominant (3 bearish vs 0 bullish) in recent technical analysis.</li> <li>Fund flow trends show a negative overall trend with mixed inflow ratios across different order sizes.</li></ul>

Key Factors

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures including mitral valve repair and cardiac revascularization.Intuitive Surgical reported Q4 2025 earnings that beat the Zacks Consensus for the 12th quarter in a row with 19% revenue growth to $2.87 billion.Intuitive Surgical shares fell 3.27% to $504.96 despite recent regulatory wins and mixed guidance from the company.

Recent Updates

ISRG News